News

A new model of the causes of breast cancer, created by a team led by researchers at UC San Francisco, Genentech and Stanford University, is designed to capture the complex interrelationships between dozens of primary and secondary breast cancer causes and stimulate further research. Breast cancer is

This month, neuro-oncologist Jessica Schulte, MD, PhD joins the UCSF Brain Tumor Center team. Dr. Schulte specializes in treatment of adolescent and adult glioma and neurofibromatosis, with a focus on optimizing transitions of care between pediatric and adult medical care. Dr. Schulte earned her

Colleagues are mourning the passing of Zena Werb, PhD, a giant in the field of cancer biology whose four decades of research at UC San Francisco informed the rise of immunotherapy and other modern approaches to cancer treatment. Werb, who was a professor in the Department of Anatomy and associate

New processes are in place as a result of COVID-19 and our priority remains the same: your health and safety.

The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco, the University of Chicago, and the University of Toronto, has entered into a second research collaboration with Celgene that aims to create and develop high-performance recombinant antibodies

A new study by researchers at UCSF Benioff Children’s Hospitals and St. Jude Children’s Research Hospital has identified what they believe to be a key reason behind patients’ treatment-resistance in the rare inflammatory disorder HLH. The finding could offer additional insights into other immune

Cancer treatment has advanced with the advent of immunotherapies that, in some cancers, can overcome tumors’ ability to evade the immune system by suppressing local immune responses. But a new study in mice by UC San Francisco researchers has found that, depending on a cancer’s tissue of origin